Maria Helena Rigatto

Author

Hospital de Clínicas de Porto Alegre ORCID

Also Known As

M Rigatto, M. H. Rigatto, M. Rigatto, M.H. Rigatto, MARIA HELENA DA SILVA PITOMBEIRA RIGATTO, Maria H. Rigatto, Maria Helena P. Rigatto, Maria Helena Rigatto, Maria Helena da Silva Pitombeira Rigatto, Rigatto, Maria Helena

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Hospital de Clínicas de Porto Alegre Universidade Federal do Rio Grande do Sul Pontifícia Universidade Católica do Rio Grande do Sul Hospital Nossa Senhora da Conceição Hospital São Lucas da PUCRS

About

Maria Helena Rigatto is an author at Hospital de Clínicas de Porto Alegre specializing in medicine, clinical microbiology, and infection control.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	484
2	Microbiology	3	3	99
3	Health Sciences	2	2	78
4	Allergy	1	1	41
5	Emergency Medicine	1	1	145

Maria Helena Rigatto

Publications

Citations

H-Index

Page 1

	Year	Citations
Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium Felipe Francisco Tuon, Maria Helena Rigatto, Cesar K. Lopes, International Journal of Antimicrobial Agents Renal FunctionMedicineRenal InflammationAcute Kidney InjuryChronic Kidney Disease	2013	145
Prevalence and risk factors for chronic bronchitis in Pelotas, RS, Brazil: a population-based study. Ana Maria B. Menezes, César G. Victora, Maria Helena Rigatto Thorax	1994	136
Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B Maria Helena Rigatto, Maura Salaroli de Oliveira, Lauro Vieira Perdigão Neto, Antimicrobial Agents and Chemotherapy Cms TherapyRenal PathologyRenal InflammationCms GroupLogistic Analysis	2016	135
Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study Maria Helena Rigatto, Tainá F. Behle, Diego R. Falci, Journal of Antimicrobial Chemotherapy	2015	130
Polymyxin B in Combination with Antimicrobials Lacking <i>In Vitro</i> Activity versus Polymyxin B in Monotherapy in Critically Ill Patients with Acinetobacter baumannii or Pseudomonas aeruginosa Infections Maria Helena Rigatto, Fabiane Jamono Vieira, Laura C. Antochevis, Antimicrobial Agents and Chemotherapy	2015	70
Polymyxin B versus other antimicrobials for the treatment of Pseudomonas aeruginosa bacteraemia Carlos Henrique Cezimbra Kvitko, Maria Helena Rigatto, A. L. Moro, Journal of Antimicrobial Chemotherapy	2010	64
Severe Infusion-Related Adverse Events and Renal Failure in Patients Receiving High-Dose Intravenous Polymyxin B Josiane França John, Diego R. Falci, Maria Helena Rigatto, Antimicrobial Agents and Chemotherapy	2017	56
Combination therapy with polymyxin B for carbapenemase-producing Klebsiella pneumoniae bloodstream infection Gregory Saraiva Medeiros, Maria Helena Rigatto, Diego R. Falci, International Journal of Antimicrobial Agents Medical MicrobiologyAntimicrobial SusceptibilityHealth SciencesAntibioticsKlebsiella Pneumoniae	2018	56
A Cohort Study of the Impact of Carbapenem-Resistant <i>Enterobacteriaceae</i> Infections on Mortality of Patients Presenting with Sepsis Sabrina Sabino, Sílvia Pedroso Tavares Soares, Fabiano Ramos, mSphere	2019	50
AIRWAYS OBSTRUCTION BEFORE AND AFTER ISOPRENALINE, HISTAMINE, AND PREDNISOLONE IN PATIENTS WITH CHRONIC OBSTRUCTIVE BRONCHITIS Edward Anthony Oppenheimer, Maria Helena Rigatto, C. M. Fletcher The Lancet AsthmaAllergyRespiratory DiseasesRespiratory InfectionMedicine	1968	41

Page 1